JWH-210
JWH-210 is a synthetic cannabinoid from the naphthoylindole family, which acts as a potent cannabinoid receptor agonist. It was discovered by and named after Dr. John W. Huffman.
Chemistry[edit | edit source]
JWH-210 is a analgesic chemical from the naphthoylindole family, which acts as a potent cannabinoid receptor agonist. Its binding affinity at the CB1 receptor is 32nM, while its binding affinity at the CB2 receptor is 12nM.
Effects[edit | edit source]
JWH-210 may cause intense episodes of psychosis, particularly in those already predisposed to such conditions. It may also cause palpitations, anxiety, panic attacks, disorientation, and severe paranoia. Long-term effects include addiction and withdrawal symptoms.
Legal Status[edit | edit source]
JWH-210 is a Schedule I controlled substance in the United States. It is also illegal in many other countries.
See Also[edit | edit source]
References[edit | edit source]
JWH-210 Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD